Genome editing using CRISPR/Cas9 to introduce the mutations detected in malignant mesothelioma patients into TSCE5 cells and functional assays.

○Shinsei Fujino, Misato Kimura, Mai Imasaka, Masaki Ohmuraya, Yoshie Yoshikawa

[3P-0097] Genome editing using CRISPR/Cas9 to introduce the mutations detected in malignant mesothelioma patients into TSCE5 cells and functional assays.

○Shinsei Fujino^1,2, Misato Kimura², Mai Imasaka², Masaki Ohmuraya², Yoshie Yoshikawa² (1.Dept. of Biosci., Grad. Sch. of Sci. Tec., Kwansei Gakuin Univ., 2.Dept. of genetics., Hyogo College Of Medicine)

malignant mesothelioma, CRISPR/Cas9

This archive has moved to the member page of The Molecular Biology Society of Japan.
Members can access the abstracts via links at the member page of the sites.
Please feel free to contact the journal offices for any inquiries.

The 43rd Annual Meeting of the Molecular Biology Society of Japan

[3P-0097] Genome editing using CRISPR/Cas9 to introduce the mutations detected in malignant mesothelioma patients into TSCE5 cells and functional assays.

Password